Announcement of participation in BioJapan 2025 and presentation at the luncheon seminar.

ザルトリウス・ステディム・ジャパン

We will be exhibiting and presenting a luncheon seminar at BioJapan 2025, which will be held at Pacifico Yokohama from October 8 to 10, 2025. At our booth, we will introduce our cell line development services and media optimization services that achieve a scalable fed-batch process with a monoclonal antibody titer of up to 10 g/L in just 9 weeks, from DNA to RCB. We will also showcase single-use culture vessels for process development. In addition, during the luncheon seminar, we will provide a clear overview of Sartorius' CLD services, making it easy to understand for those who are new to the topic. If you are considering shortening timelines, optimizing product quality, or exploring flexible development strategies, please join us. We look forward to seeing you there. Event Overview: October 8 (Wed) - 10 (Fri), 2025, Pacifico Yokohama Exhibition Booth: Small Booth Number D-109 Luncheon Seminar: Title: Minimizing Risks in CHO Cell Line Development through Automation and Predictive Models Seminar Date and Time: October 9 (Thu) 11:30 AM - 12:30 PM

Date and time Wednesday, Oct 08, 2025 ～ Friday, Oct 10, 2025
Our company's luncheon seminar date: October 9th (Thursday) 11:30 AM ~ 12:30 PM
Capital Pacifico Yokohama 〒220-0012 Kanagawa Prefecture, Yokohama City, Nishi Ward, Minato Mirai 1-1-1
Entry fee Free

Related product information

4Cell CHO Platform
Protein characterization analysis, cell banking, safety testing services

The foundation for the approval of new biopharmaceuticals is formed by a robust analytical data package that demonstrates the safety, purity, and efficacy of the product. Sartorius's analytical testing package combines physicochemical analysis methods with biological analysis methods, providing detailed characterization tailored to each customer. Our services enable rapid data-driven decision-making during drug development using platform methods, off-the-shelf assays, and custom-developed bioassays, available from preclinical to clinical stages and lot release.
Cell line development and upstream process services
Using Cellca cell line development, over 120 projects have been successfully completed.

【Main Elements】 ▪ Cell lines & tests ▪ 4Cell CHO medium system ▪ Expression vector ▪ Upstream process
4Cell CHO Media & Feed Portfolio
For protein production using CHO cell lines.

The Zaltorius CHO medium portfolio has been developed for the culture of Chinese hamster ovary (CHO) and other mammalian cell lines. CHO cells can be used for both stable expression and transient expression of recombinant proteins.
Optimization of CHO cell culture process based on DOE in Ambr15.
CHO Cell Culture Optimization: A DOE Approach in the Ambr 15

For more details, please refer to the PDF document or feel free to contact us.
Univessel SU Single-Use Culture Vessel
Single-use culture vessel with a proven design.

Univessel SU is a single-use bioreactor for stirring tanks. It combines a proven scalable glass bioreactor design with the rapid turnover of a single-use system. The Univessel SU is compatible with your controller and helps efficiently manage peak workloads even on tight schedules by allowing for the exchange of glass containers.